Holen Sie sich die Stockscreener-App
2.35
1.26%
-0.03
Schlusskurs vom Vortag:
$2.38
Offen:
$2.46
24-Stunden-Volumen:
19,200
Relative Volume:
0.28
Marktkapitalisierung:
$5.79M
Einnahmen:
$77,900
Nettoeinkommen (Verlust:
$-8.05M
KGV:
-0.2546
EPS:
-9.2296
Netto-Cashflow:
$-7.47M
1W Leistung:
+16.63%
1M Leistung:
-23.95%
6M Leistung:
-0.42%
1J Leistung:
-68.24%
1-Tages-Spanne:
$2.28
$2.46
1-Wochen-Bereich:
$1.95
$2.48
52-Wochen-Spanne:
$1.95
$12.03
Aclarion Inc Stock (ACON) Company Profile
Firmenname
Aclarion Inc
Sektor
Branche
Telefon
833 275 2266
Adresse
8181 ARISTA PLACE, BROOMFIELD
Compare ACON vs VEEV, BTSG, HQY, TEM, HNGE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ACON
Aclarion Inc
|
2.35 | 5.47M | 77,900 | -8.05M | -7.47M | -9.2296 |
VEEV
Veeva Systems Inc
|
212.80 | 31.59B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
62.85 | 14.13B | 13.65B | 169.86M | 412.12M | 1.0758 |
HQY
Healthequity Inc
|
104.42 | 8.28B | 1.34B | 230.70M | 440.96M | 2.6695 |
TEM
Tempus Ai Inc
|
46.87 | 7.73B | 1.36B | -302.91M | -219.93M | -1.7182 |
HNGE
Hinge Health Inc
|
81.14 | 5.81B | 646.34M | -512.40M | 202.76M | -6.6871 |
Aclarion Inc Aktie (ACON) Neueste Nachrichten
Aclarion, Inc. Revenue Breakdown – BOATS:ACON - TradingView
Aclarion Inc (ACON) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Aclarion Inc (ACON) Institutional Confidence - TradingKey
Aclarion Inc (ACON) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Aclarion Inc (ACON) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Aclarion Inc (ACON) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
ACON|Aclarion Inc|Price:2.420|Chg%:-0.030 - TradingKey
Aclarion Market Sentiment - Benzinga España
TradingKey - TradingKey
Aclarion, Inc. Revenue Breakdown – TRADEGATE:IT20 - TradingView
Aclarion, Inc. Revenue Breakdown – NASDAQ:ACONW - TradingView
Aclarion Inc (ACON) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Aclarion Announces Presentation of Two Abstracts Highlighting Nociscan’s Growing Role in Real-World Clinical Practice - Ortho Spine News
Aclarion Nociscan Case Reports 95% Relief Without Classic MRI Signs - Stock Titan
Aclarion, Inc. Warrant 2022- on Aclarion Financial Disclosures & SEC Filings - TradingView
Return on equity % of Aclarion, Inc. – TRADEGATE:IT20 - TradingView
Aclarion Inc. (ACON) Slides 2.6% as Support Levels Face Renewed PressureDouble Bottom - dars.gov.et
Aclarion Inc. (ACON) Faces Resistance After 5.41% Decline – Key Levels in FocusRatio Spread Trade - dars.gov.et
Price to sales forward of Aclarion, Inc. – NASDAQ:ACONW - TradingView
Number of shareholders of Aclarion, Inc. – NASDAQ:ACONW - TradingView
Price to earnings forward of Aclarion, Inc. – BOATS:ACONW - TradingView
ACON Q1 2026 Earnings: EPS Surprises to the Upside Despite Stock DeclinePerformance Review - DonanımHaber
Aclarion Inc. (ACON) Consolidates Near $3.02 as Micro-Cap Healthcare Stock Eyes Resistance at $3.17Bullish Sentiment - dars.gov.et
Aclarion Announces Texas Spine Care Center as New CLARITY Site - marketscreener.com
Aclarion adds Texas Spine Care Center to CLARITY trial By Investing.com - Investing.com Nigeria
Aclarion adds Texas Spine Care Center to CLARITY trial - Investing.com
Aclarion expands CLARITY trial with Texas spine center - Stock Titan
Aclarion Inc. Warrant (ACONW) Slips 6.85%, Hovers at Critical $0.02 LevelBreakaway Gap - dars.gov.et
Aclarion Inc. Warrant (ACONW) Slips Again: Warrants Trade Near $0.02 Amid Thin VolumeShort Term Trading Ideas - dars.gov.et
ACONW Extends Decline: A Closer Look at Aclarion Inc. WarrantsAnalyst Upgrade Stocks - dars.gov.et
Aclarion Inc. Q1 2026 Earnings: EPS Surprise Drives Stock Rally Amid Revenue AbsenceEarnings Turnaround - dars.gov.et
ACON Q1 2026 Earnings: EPS Surpasses Analyst Estimates Despite Lack of Revenue DisclosureFull Year Guidance - dars.gov.et
Enterprise value to EBIT forward of Aclarion, Inc. – NASDAQ:ACON - TradingView
Price to book forward of Aclarion, Inc. – NASDAQ:ACON - TradingView
A412BH Forecast — Price Target — Prediction for 2027 - TradingView
Aclarion, Inc. Actuals & Estimates (NASDAQ:ACON) - TradingView
ACON Forecast — Price Target — Prediction for 2027 - TradingView
Aclarion Inc (ACONW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Aclarion Inc. (ACON) Q1 2026 Earnings: Narrower-than-expected Loss Drives EPS Beat, Yet Shares Slide 4.9%EPS Growth Report - DonanımHaber
Aclarion Inc. (ACON) Q1 2026 Earnings: EPS Surpasses Estimates with 15% Beat Despite No RevenueGAAP Earnings Report - dars.gov.et
Aclarion Inc (ACONW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
ACON Q1 2026 Earnings: EPS Surprises Positively Despite Absence of RevenueAdjusted Earnings Analysis - Bölüm Sonu Canavarı
Aclarion Inc. Warrant (ACONW) Surges 38% From Penny Levels – But Caution WarrantedBPI Bull Correction - Město Břeclav
Aclarion Inc. Holds Steady Near Key Resistance Level (ACON)RTH Profile - dars.gov.et
Aclarion (ACON) upgraded to buy: Here's why - MSN
Aclarion Inc (ACONW) Valuation: PE, PB & Fair Value Analysis - TradingKey
Aclarion Inc (ACONW) Institutional Confidence - TradingKey
Aclarion Inc (ACONW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Aclarion Inc (ACONW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Aclarion Inc (ACONW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Aclarion Inc (ACONW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Finanzdaten der Aclarion Inc-Aktie (ACON)
Umsatz
Nettogewinn
Free Cashflow
ENV
Aclarion Inc-Aktie (ACON) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Neal David K | Director |
May 11 '26 |
Buy |
3.10 |
2,500 |
7,750 |
2,502 |
| Ness Brent | Chief Executive Officer |
May 11 '26 |
Buy |
3.18 |
6,289 |
19,999 |
6,300 |
| Wesemann William | Director |
May 06 '26 |
Buy |
3.30 |
1,562 |
5,155 |
1,563 |
| Ness Brent | Chief Executive Officer |
Nov 26 '25 |
Buy |
6.20 |
10 |
62 |
11 |
1.18%
2.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):